Liminal BioSciences Inc - Company Profile
Powered by 
All the sales intelligence you need on Liminal BioSciences Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Liminal BioSciences Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Liminal BioSciences Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Liminal BioSciences Inc (Liminal) is a biopharmaceutical company. It is focused on developing novel small-molecule therapeutics for metabolic, fibrotic, and inflammatory diseases. The company’s lead programs include a GPR84 antagonist (LMNL6511) for conditions like Non-Alcoholic Steatohepatitis (NASH), Inflammatory Bowel Disease (IBD), and Idiopathic Pulmonary Fibrosis (IPF), which is progressing toward Phase 1 trials. Liminal is developing a selective OXER1 antagonist to treat eosinophilic-driven diseases such as asthma and atopic dermatitis. The company is also working on a liver-safe GPR40 agonist for Type 2 diabetes, focusing on glucose-dependent insulin secretion and liver safety in its drug candidates. Liminal is headquartered in Laval, Quebec, Canada.
Headquarters
Canada
Address
West, Suite 150, 500 Cartier Boulevard, Laval, Quebec, H7V5B7
Website
www.liminalbiosciences.com
Telephone
1 450 7810115
Industry
Pharmaceuticals and Healthcare
Liminal BioSciences Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline: |
| GPR84 Antagonist: Non-Alcoholic Steatohepatitis, Inflammatory Bowel Disease and Idiopathic Pulmonary Fibrosis |
| OXER1 Antagonist: Eosinophilic-Driven Asthma and Atopic Dermatitis |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Liminal BioSciences Inc | Zymeworks Inc | Celyad Inc | Mabylon AG | Protokinetix Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | United States of America | United States of America | Switzerland | United States of America |
| City | Laval | Middletown | New York City | Schlieren | Dalton |
| State/Province | Quebec | Delaware | New York | Zurich | Ohio |
| No. of Employees | - | 264 | - | - | - |
| Entity Type | Private | Public | Private | Private | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bruce Pritchard | Chief Executive Officer | Senior Management | 2020 | - |
| Marie Iskra | Secretary; General Counsel | Senior Management | - | - |
| Gary Bridger | Interim Chief Scientific Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer